Swiss pharmaceutical group Roche agrees to acquire US-based PathAI, which makes AI diagnostic tools, for up to $1.05B, with $750M upfront, closing in H2 2026 (Adrià Calatayud/Wall Street Journal)

<a href="https://www.wsj.com/business/deals/roche-to-buy-pathai-for-up-to-1-05-billion-to-bolster-ai-diagnostics-tools-0b4575ee?st=jvDA1b&amp;reflink=desktopwebshare_permalink"><img align="RIGHT" border="0" hspace="4" src="http://www.techmeme.com/260507/i8.jpg" vspace="4" /></a> <p><a href="https://www.techmeme.com/260507/p8#a260507p8" title="Techmeme permalink"><img height="12" src="http://www.techmeme.com/img/pml.png" style="border: none; padding: 0; margin: 0;" width="11" /></a> Adri&agrave; Calatayud / <a href="https://www.wsj.com/">Wall Street Journal</a>:<br /> <span style="font-size: 1.3em;"><b><a href="https://www.wsj.com/business/deals/roche-to-buy-pathai-for-up-to-1-05-billion-to-bolster-ai-diagnostics-tools-0b4575ee?st=jvDA1b&amp;reflink=desktopwebshare_permalink">Swiss pharmaceutical group Roche agrees to acquire US-based PathAI, which makes AI diagnostic tools, for up to $1.05B, with $750M upfront, closing in H2 2026</a></b></span>&nbsp; &mdash;&nbsp; The pharma giant has agreed to pay $750 million upfront, with up to $300 million in additional payments subject to targets</p>